Pathogenesis of myeloma bone disease

被引:278
|
作者
Roodman, G. D. [1 ]
机构
[1] Univ Pittsburgh, Vet Affairs Pittsburgh Healthcare Syst, Dept Med Hematol Oncol, Sch Med, Pittsburgh, PA 15240 USA
关键词
multiple myeloma; osteoclast; osteoblast; bone disease; KAPPA-B LIGAND; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR-NECROSIS-FACTOR; MULTIPLE-MYELOMA; RECEPTOR ACTIVATOR; IN-VIVO; INHIBITS OSTEOCLASTOGENESIS; OSTEOBLAST DIFFERENTIATION; MARROW MICROENVIRONMENT; PROTEASOME INHIBITOR;
D O I
10.1038/leu.2008.336
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bone disease in multiple myeloma (MM) is characterized by lytic bone lesions, which can cause severe bone pain, pathologic fractures and hypercalcemia. However, the lytic bone disease in MM differs from that in other cancer patients who have lytic bone metastases. Although increased osteoclastic bone destruction is involved in MM and other tumors involving bone, in contrast to other tumors, once the MM tumor burden exceeds 50% in a local area, osteoblast activity is either suppressed or absent. 1 The basis for this severe imbalance between increased osteoclastic bone resorption and decreased bone formation has been a topic of intensive investigation over the last several years and will be reviewed in this article.
引用
收藏
页码:435 / 441
页数:7
相关论文
共 50 条
  • [1] Pathogenesis of myeloma bone disease
    Roodman, GD
    BLOOD CELLS MOLECULES AND DISEASES, 2004, 32 (02) : 290 - 292
  • [2] Pathogenesis of myeloma bone disease
    G D Roodman
    Leukemia, 2009, 23 : 435 - 441
  • [3] Pathogenesis of Myeloma Bone Disease
    Roodman, G. David
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2010, 109 (02) : 283 - 291
  • [4] Myeloma bone disease: Progress in pathogenesis
    Xi, Hao
    An, Ran
    Li, Lu
    Wang, Gang
    Tao, Yi
    Gao, Lu
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2016, 122 (02): : 149 - 155
  • [5] The pathogenesis of the bone disease of multiple myeloma
    Edwards, Claire M.
    Zhuang, Junling
    Mundy, Gregory R.
    BONE, 2008, 42 (06) : 1007 - 1013
  • [6] Pathogenesis and management of myeloma bone disease
    Christoulas, Dimitrios
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (04) : 385 - 398
  • [7] Pathogenesis and treatment of multiple myeloma bone disease
    Hiasa, Masahiro
    Harada, Takeshi
    Tanaka, Eiji
    Abe, Masahiro
    JAPANESE DENTAL SCIENCE REVIEW, 2021, 57 : 164 - 173
  • [8] Pathogenesis and Treatment of Myeloma-Related Bone Disease
    Gau, Yuh-Ching
    Yeh, Tsung-Jang
    Hsu, Chin-Mu
    Hsiao, Samuel Yien
    Hsiao, Hui-Hua
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
  • [9] Myeloma bone disease: Pathogenesis and treatment - From the multiple myeloma research foundation
    Anderson, KC
    Roodman, GD
    ONCOLOGY-NEW YORK, 2005, 19 (08): : 983 - +
  • [10] Pathogenesis of bone disease in multiple myeloma: from bench to bedside
    Terpos, Evangelos
    Ntanasis-Stathopoulos, Ioannis
    Gavriatopoulou, Maria
    Dimopoulos, Meletios A.
    BLOOD CANCER JOURNAL, 2018, 8